These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39600104)
1. Dodecanedioic acid prevents and reverses metabolic-associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet-induced obesity. Angelini G; Russo S; Carli F; Infelise P; Panunzi S; Bertuzzi A; Caristo ME; Lembo E; Calce R; Bornstein SR; Gastaldelli A; Mingrone G FASEB J; 2024 Nov; 38(22):e70202. PubMed ID: 39600104 [TBL] [Abstract][Full Text] [Related]
2. Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767. Ramachandran P; Brice M; Sutherland EF; Hoy AM; Papachristoforou E; Jia L; Turner F; Kendall TJ; Marwick JA; Carragher NO; Oro D; Feigh M; Leeming DJ; Nielsen MJ; Karsdal MA; Hartmann N; Erickson M; Adorini L; Roth JD; Fallowfield JA Hepatol Commun; 2024 Dec; 8(12):. PubMed ID: 39585303 [TBL] [Abstract][Full Text] [Related]
3. Sexual dimorphism in the effects of maternal adipose tissue growth hormone receptor deficiency on offspring metabolic health. Ran L; Wang X; Ma R; Wang H; Wu Y; Yu Z Biol Sex Differ; 2024 Dec; 15(1):98. PubMed ID: 39623508 [TBL] [Abstract][Full Text] [Related]
4. Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease. Taghizadeh M; Maleki MH; Vakili O; Tavakoli R; Zarei P; Dehghanian A; Bordbar H; Shafiee SM Sci Rep; 2024 Nov; 14(1):29244. PubMed ID: 39587213 [TBL] [Abstract][Full Text] [Related]
6. Lingguizhugan decoction alleviates obesity in rats on a high-fat diet through the regulation of lipid metabolism and intestinal microbiota. Huang W; Wang J; Xiao Z; Lin J; Tan Z; Sun G Front Microbiol; 2024; 15():1462173. PubMed ID: 39606109 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis. Engin A Adv Exp Med Biol; 2024; 1460():539-574. PubMed ID: 39287864 [TBL] [Abstract][Full Text] [Related]
8. Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease. Huang L; Rao Q; Wang C; Mou Y; Zheng X; Hu E; Zheng J; Li Y; Liu L Phytomedicine; 2024 Dec; 135():156026. PubMed ID: 39388921 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
11. Calcium supplementation for people with overweight or obesity. Cormick G; Ciapponi A; Harbron J; Perez SM; Vazquez P; Rivo J; Metzendorf MI; Althabe F; Belizán JM Cochrane Database Syst Rev; 2024 May; 5(5):CD012268. PubMed ID: 38721870 [TBL] [Abstract][Full Text] [Related]
12. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature. Corcione S; Lupia T; Vita D; Sidoti F; Zanotto E; Solidoro P; Biancone L; Costa C; Balagna R; De Rosa FG Transplant Rev (Orlando); 2024 Dec; 38(4):100873. PubMed ID: 39178643 [TBL] [Abstract][Full Text] [Related]
15. Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study. Martínez-Montoro JI; Arranz-Salas I; Gutiérrez-Repiso C; Sánchez-García A; Ocaña-Wilhelmi L; Pinazo-Bandera JM; Fernández-García D; Muñoz-Garach A; Morales-García D; García-Cortés M; García-Fuentes E; Tinahones FJ; Garrido-Sánchez L Nutrients; 2024 Nov; 16(22):. PubMed ID: 39599643 [TBL] [Abstract][Full Text] [Related]
16. Suppression of intestinal Ticam1 ameliorated MASH via Akkermansia muciniphila QAA37749.1 mediated betaine transformation. Li Z; Gao W; Yuan H; Pan X; Yuan R; Wang W; Guan L; Hu L; Chen Y; Cheng Z; He R; Zhang L; Yang B; Zhu Q; Liang M; Seki E; Lin R; Chu H; Yang L Biochim Biophys Acta Mol Basis Dis; 2025 Jan; 1871(1):167571. PubMed ID: 39536991 [TBL] [Abstract][Full Text] [Related]
17. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients. Maung Myint T; Chong CH; von Huben A; Attia J; Webster AC; Blosser CD; Craig JC; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014839. PubMed ID: 39606952 [TBL] [Abstract][Full Text] [Related]
18. Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome. Felicianna ; Lo EKK; Chen C; Ismaiah MJ; Zhang F; Leung HKM; El-Nezami H Mol Metab; 2024 Dec; 90():102059. PubMed ID: 39489290 [TBL] [Abstract][Full Text] [Related]